Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Biobased Chemicals
Bluestem Biosciences raises $5 million for chemical fermentation
by Matt Blois
August 14, 2022
| A version of this story appeared in
Volume 100, Issue 28
Bluestem Biosciences, a synthetic biology start-up, has raised $5 million in seed financing to pursue the production of chemicals via anaerobic fermentation. The company told the trade group Bio Nebraska it plans to license yeast strains and fermentation processes to companies that own fermentation infrastructure. Bluestem will use computational tools to develop a product pipeline. The company’s team includes alumni from synthetic biology companies such as Ginkgo Bioworks, Zymergen, and Amyris.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter